496
J. Christoffers et al.
LETTER
(6) (a) Andrews, D. M.; Carey, S. J.; Chaignot, H.; Coomber, B.
A.; Gray, N. M.; Hind, S. L.; Jones, P. S.; Mills, G.;
Robinson, J. E.; Slater, M. J. Org. Lett. 2002, 4, 4475.
(b) Tsujimoto, T.; Ishihara, J.; Horie, M.; Murai, A. Synlett
2002, 399. (c) Ishihara, J.; Horie, M.; Shimada, Y.; Tojo, S.;
Murai, A. Synlett 2002, 403. (d) Hughes, R. C.; Dvorak, C.
A.; Meyers, A. I. J. Org. Chem. 2001, 66, 5545. (e) Enders,
D.; Teschner, P.; Raabe, G.; Runsink, J. Eur. J. Org. Chem.
2001, 4463.
mmol, 56%), mp 66 °C, [α]D20 = +115 (c 1.5, CHCl3), >99%
ee; [α]D20 +107 (c 3.5, EtOH), >99% ee.12 1H NMR (CDCl3,
500 MHz): δ (ppm) = 2.00–2.05 (m, 1 H), 2.03 (s, 3 H), 2.11
(dt, J = 12.8 Hz, J = 8.5 Hz, 1 H), 2.30 (dt, J = 19.0 Hz,
J = 5.7 Hz, 1 H), 2.44 (ddd, J = 5.4 Hz, J = 6.6 Hz, J = 12.2
Hz, 1 H), 2.71 (ddd, J = 3.7 Hz, J = 7.2 Hz, J = 10.9 Hz, 1
H), 2.75 (dt, J = 12.2 Hz, J = 6.0 Hz, 1 H), 4.34–4.44 (m, 2
H), 5.9 (sextet, J = 1.0 Hz, 1 H). 13C{1H} NMR (CDCl3, 50
MHz): δ (ppm) = 24.41 (CH3), 27.96 (CH2), 30.79 (CH2),
32.65 (CH2), 52.66 (C), 65.95 (CH2), 124.31 (CH), 164.08
(C), 175.64 (C), 194.27 (C). IR (ATR): 2923 (s), 1766 (vs),
1655 (vs), 1630 (s), 1376 (s), 1217 (s), 1185 (vs), 1137 (s),
1060 (s), 1015 (vs), 985 (s) cm–1. HRMS calcd for C10H12O3:
180.0786. Found: 180.0781 [M+]. Anal. Calcd for C10H12O3:
C, 66.65; H, 6.71. Found: C, 66.82; H, 6.73.
(7) (S,S)-N-(8-Methyl-1-oxo-2-oxaspiro[4.5]dec-7-en-6-
ylidene)-L-valine dimethylamide (5a). A solution of 4a
(304 mg, 1.20 mmol) and Cu(OAc)2·H2O (12.0 mg, 0.060
mmol) in acetone (5 mL) was stirred at r.t. for 1 h. After
addition of 2 (0.17 g, 2.4 mmol), the reaction mixture was
stirred for 16 h. All volatile materials were removed under
high vacuum and the crude product was purified by
chromatography on SiO2 (EtOAc, Rf 0.26) to give 5a as a
colorless solid (197 mg, 0.643 mmol, 54%), mp 87–89 °C,
[α]D20 +15 (c 2.5, CHCl3). 1H NMR (CDCl3, 400 MHz): δ
(ppm) = 0.85 (d, J = 6.5 Hz, 3 H), 0.95 (d, J = 6.7 Hz, 3 H),
1.76–1.84 (m, 1 H), 1.91 (s, 3 H), 2.10–2.42 (m, 6 H), 2.85
(s, 3 H), 3.03 (s, 3 H), 3.98 (d, J = 9.8 Hz, 1 H), 4.28–4.42
(m, 2 H), 6.26 (br s, 1 H). 13C{1H} NMR (CDCl3, 50 MHz):
δ (ppm) = 19.46 (CH3), 20.57 (CH3), 24.43 (CH3), 27.96
(CH2), 30.96 (CH2), 31.27 (CH), 34.34 (CH2), 36.20 (CH3),
37.11 (CH3), 51.02 (C), 65.31 (CH2), 73.56 (CH), 114.43
(CH), 152.92 (C), 165.06 (C), 171.59 (C), 178.72 (C). IR
(ATR): 2961 (s), 2931 (s), 1772 (vs), 1635 (vs), 1386 (s),
1216 (s), 1184 (vs), 1030 (s) cm–1. HRMS calcd for
C17H26N2O3: 306.1943. Found: 306.1945. Anal. Calcd for
C17H26N2O3: C, 66.64; H, 8.55; N, 9.14. Found: C, 66.27; H,
8.17; N, 8.96.
(9) Compound 6a was reported before with higher optical
rotation of [α]D20 +149 (c 1.36, EtOH) despite lower optical
purity (86% ee), see: Felk, A.; Revial, G.; Viossat, B.;
Lemoine, P.; Pfau, M. Tetrahedron: Asymmetry 1994, 5,
1459.
(10) Of course, all compounds 6 have been prepared as racemic
materials on a larger scale and completely characterized. The
identity of the optically active compounds 6 has been
established on an analytical scale by 1H NMR spectroscopy
and gas chromatography.
(11) Crystallographic data (excluding structure factors) for the
structures reported in this paper have been deposited with the
Cambridge Crystallographic Data Centre as supplementary
publication no. CCDC-199252 (5a), no. CCDC-199251 (6c)
and no. CCDC-199250 (8). Copies of the data can be
obtained free of charge on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033 or
e-mail: deposit@ccdc.cam.ac.uk].
(8) (S)-8-Methyl-2-oxaspiro[4.5]dec-7-ene-1,6-dione(6a). To
a solution of 5a (95.0 mg, 0.296 mmol) in H2O (15.0 mL) at
0 °C was added concd H2SO4 (2 drops), and after stirring for
1 h at 0 °C, the reaction mixture was allowed to warm up to
r.t. and extracted with EtOAc (3 × 50 mL). The combined
organic layers were dried (MgSO4), the solvent evaporated,
and the crude product purified by chromatography on SiO2
[petroleum ether–EtOAc, 1:2, Rf (MTB–cyclohexane,
5:1) 0.25] to give 6a as a colorless solid (30.0 mg, 0.166
(12) The nomenclature is, of course, dependent on constitution.
Configurations of structures in Scheme 2 are: (S)-5a, (S)-5b,
(R)-5c, (S)-6a, (S)-6b, and (S)-6c.
(13) Quantitative enantiomeric purity of 6a was established by
GLC on the chiral phase Bondex-un-α-5.6-Et-57.14
(14) For preparation of the chiral phase: Scherr, O. Dissertation;
Universität Stuttgart, 1997.
(15) Stefane, B.; Polanc, S. New J. Chem. 2002, 26, 28.
Synlett 2003, No. 4, 493–496 ISSN 0936-5214 © Thieme Stuttgart · New York